Your session is about to expire
← Back to Search
Brain Function Study for Epilepsy
N/A
Recruiting
Led By Krzysztof A Bujarski, MD
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up evaluated for each patient during monitoring period of approximately 2 weeks.
Awards & highlights
No Placebo-Only Group
Summary
This trial will enroll epilepsy patients who have electrodes in their brain or on their scalp, as well as normal and online controls. The aim is to study localization and function of the human brain using intracranial electrophysiology.
Who is the study for?
This trial is for adults with refractory epilepsy who are undergoing clinical intracranial EEG recording as part of their evaluation for epilepsy surgery. It also includes healthy individuals and online participants without epilepsy to serve as controls.
What is being tested?
The study tests various aspects of human cognition in patients with electrodes implanted in the brain or on the scalp, using tasks related to memory, speech, emotions, etc., often involving computers and additional non-invasive monitoring equipment.
What are the potential side effects?
Since this study involves cognitive testing and non-invasive monitoring rather than drug treatments, side effects may include discomfort from wearing monitoring devices or fatigue from participating in lengthy cognitive tasks.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ evaluated for each patient during monitoring period of approximately 2 weeks.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~evaluated for each patient during monitoring period of approximately 2 weeks.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Using scalp and intracranial EEG, measure changes in electrical activity of the human brain associated with attention and executive function.
Using scalp and intracranial EEG, measure changes in electrical activity of the human brain associated with emotions.
Using scalp and intracranial EEG, measure changes in electrical activity of the human brain associated with language.
+3 moreSecondary study objectives
Measure the degree of correlation between the brain activation and cardiac physiology.
Measure the degree of correlation between the brain activation and sweat variations.
The degree of correlation between the brain activation and electrodermal activity.
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Scalp EEG (electrodes are placed on a participant's scalp)Experimental Treatment8 Interventions
Patients with non-invasive scalp electrodes who are admitted to the hospital for clinical reasons will be asked to participate in various study tasks with the recording of their EEG (recording of brain waves via electrodes attached to a participant's scalp) during these tasks.
Group II: Invasive EEG (electrodes are implanted in a participant's brain)Experimental Treatment9 Interventions
Patients with intracranial electrodes (electrodes are implanted in a participant's brain) undergoing pre-surgical evaluation for clinical reasons will be asked to participate in various study tasks with the recording of intracranial EEG (recording of brain waves via electrodes implanted in a participant's brain) during these tasks.
Group III: Normal ControlsActive Control7 Interventions
Normal controls will be recruited from family members of patients, from advertisements, or from online tools. There will be no EEG recordings obtained from these participants.
Group IV: Online ControlsActive Control7 Interventions
Certain control subjects will be recruited through Amazon Mechanical Turk. These participants will be given their task on the online platform using Qualtric survey function. The task design will be identical to normal controls who are recruited in-person, with the exception of identifiers. There will be no EEG recordings obtained from these participants.
Find a Location
Who is running the clinical trial?
Dartmouth-Hitchcock Medical CenterLead Sponsor
539 Previous Clinical Trials
2,539,590 Total Patients Enrolled
13 Trials studying Epilepsy
999 Patients Enrolled for Epilepsy
Dartmouth CollegeOTHER
86 Previous Clinical Trials
1,419,563 Total Patients Enrolled
1 Trials studying Epilepsy
24 Patients Enrolled for Epilepsy
Brown UniversityOTHER
466 Previous Clinical Trials
698,890 Total Patients Enrolled
3 Trials studying Epilepsy
299 Patients Enrolled for Epilepsy
Krzysztof A Bujarski, MDPrincipal InvestigatorDartmouth-Hitchcock Medical Center
1 Previous Clinical Trials
16 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years or older and may need a scalp EEG.I am 18 years or older and may have an intracranial EEG.I am 18 years or older and do not have the condition being studied.I have hard-to-treat epilepsy and am undergoing special brain monitoring.I have an intracranial EEG but no other neurological or psychiatric conditions.My EEG results suggest I likely have epilepsy.
Research Study Groups:
This trial has the following groups:- Group 1: Normal Controls
- Group 2: Online Controls
- Group 3: Invasive EEG (electrodes are implanted in a participant's brain)
- Group 4: Scalp EEG (electrodes are placed on a participant's scalp)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.